See also this year's filing and all EDGAR filings for this company.
PDF Report 0001589150_2018_Regen_BioPharma_Inc.pdf
Logs
| warning | No LiabilitiesAndStockholdersEquity node found | input.sec.calculation_linkbase.edgar_model_mapping | {'lase_node': None, 'equity_node': None, 'partners_cap_node': None, 'nodes': "NodeView(('AssetsCurrent', 'Assets', 'OtherAssets', 'Cash', 'AccountsAndNotesReceivableNet', 'PrepaidExpenseCurrent', 'InterestReceivableCurrent', 'DueFromFormerEmployees', 'AccountsReceivableNetCurrent', 'NotesReceivableRelatedParties', 'LiabilitiesCurrent', 'Liabilities', 'TotalLongTermLiabilities', 'AccountsPayableCurrent', 'NotesAndLoansPayable', 'AccruedPayrollTaxesCurrent', 'AccruedLiabilitiesAndOtherLiabilities', 'AccruedRent', 'AccountsPayableAndAccruedLiabilitiesCurrent', 'OtherAccruedExpenses', 'DueToShareholder', 'DueToInvestor', 'DerivativeLiabilities', 'ConvertibleNotesPayable', 'AvailableForSaleSecurities', 'ConvertibleLongTermNotesPayable'))"} |
| warning | Missing logo | subcommand.report | {} |
| info | Failed to set obs_EconomicCapitalRatio | industry.us_generic | {'reason': "KeyError('0001589150')"} |
| info | Added remainder_ComprehensiveNetIncome directly from 10K | industry.us_generic | {} |
Graph
Absolute values for 0001589150, Regen BioPharma Inc
| xvar | xval | |
|---|---|---|
| 0 | AssetsCurrent | 478,387 |
| 1 | IntangibleAssetsNetIncludingGoodwill | 0 |
| 2 | PropertyPlantAndEquipmentNet | 0 |
| 3 | remainder_Assets | 465,852 |
| 4 | LiabilitiesCurrent | 5,863,164 |
| 5 | LiabilitiesNoncurrent | 0 |
| 6 | remainder_Liabilities | 332,409 |
| 7 | CostOfGoodsAndServicesSold | 0 |
| 8 | SellingGeneralAndAdministrativeExpense | 822,076 |
| 9 | ResearchAndDevelopmentExpense | 1,149,663 |
| 10 | remainder_Expenses | 649,146 |
| 11 | remainder_Revenues | 110,000 |
| 12 | remainder_NetIncome | -3,328,153 |
| 13 | remainder_ComprehensiveNetIncome | 168,000 |
| yvar | yval | |
|---|---|---|
| 0 | Assets | 944,239 |
| 1 | Liabilities | 6,195,573 |
| 2 | Expenses | 2,620,885 |
| 3 | Revenues | 110,000 |
| 4 | StockholdersEquity | -5,251,334 |
| 5 | NetIncome | -5,839,038 |
| 6 | ComprehensiveNetIncome | -5,755,038 |
| 7 | BaseVar | 6,683,425 |
| 8 | EconomicCapitalRatio | -4.14 |
Edgar->Model Mapping
Feature Distribution
Change over Time
